Infliximab in the treatment of rheumatoid arthritis
A PerdrigerService de Rhumatologie, CHU de Rennes, Hôpital sud, FranceAbstract: Infliximab was the first monoclonal antibody to human necrosis factor alpha (TNFα) developed for treating rheumatoid arthritis (RA). This chimeric antibody binds with high affinity to both sol...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://doaj.org/article/554ecbfae3e64be7879d8d47ef843e6e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|